Jaana M Hartikainen

8PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer geneticsRadiation therapyLiquid biopsiesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 18, 2024
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.

Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi

|Jul 04, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Anna Morra, Maartje A C Schreurs, Irene L Andrulis

|Aug 17, 2022
Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.

Omid Azimzadeh, Simone Moertl, Raghda Ramadan

|Mar 10, 2022
Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors.

Jouni Kujala, Jaana M Hartikainen, Maria Tengström

|Jun 15, 2021
Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells.

Kaisa-Mari Launonen, Ville Paakinaho, Gianluca Sigismondo

|Jun 02, 2021
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

JooYong Park, Ji-Yeob Choi, Jaesung Choi

Pageof 2

Frequent Collaborators

2 joint publications

Jouni Kujala

2 joint publications

Ville Paakinaho

2 joint publications

Heli Nevanlinna

2 joint publications

Thilo Dörk